Kyongbo Pharmaceutical Co., Ltd (KRX:214390)

Kyongbo Pharmaceutical Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	5,198	7,228	4,128	4,477	6,348	4,290
Short-Term Investments	820	820	2,000	870	870	-
Cash & Short-Term Investments	9,951	8,048	6,128	5,347	7,218	4,290
Cash Growth	154.54%	31.34%	14.60%	-25.92%	68.25%	-79.55%
Accounts Receivable	63,088	63,268	51,624	56,160	50,202	46,906
Other Receivables	418.42	1,392	686.7	697.94	597.63	988.69
Receivables	63,506	64,660	52,311	56,858	50,799	47,895
Inventory	77,546	80,977	90,585	70,664	57,443	57,670
Prepaid Expenses	1,525	694.32	1,311	1,610	115.43	913.7
Other Current Assets	4,393	4,758	1,606	1,423	749.74	397.53
Total Current Assets	156,920	159,138	151,941	135,902	116,326	111,166
Property, Plant & Equipment	147,990	128,023	99,852	96,073	93,919	95,677
Long-Term Investments	10,366	10,202	11,121	13,676	11,935	14,384
Other Intangible Assets	4,109	3,880	4,008	3,641	3,221	3,355
Long-Term Deferred Tax Assets	13,712	13,587	13,565	13,203	11,951	10,179
Other Long-Term Assets	5,969	4,708	3,399	3,810	3,194	2,218
Total Assets	339,067	319,538	283,887	266,305	240,545	236,979

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	14,785	14,771	14,951	22,775	14,742	16,404
Accrued Expenses	2,716	4,102	3,537	3,398	2,793	2,553
Short-Term Debt	116,345	101,321	89,271	73,095	63,900	55,234
Current Portion of Long-Term Debt	-	-	45	90	90	90
Current Portion of Leases	953.09	1,010	1,074	1,078	280.59	787.02
Current Income Taxes Payable	-	-	86.85	118.34	166.28	-
Other Current Liabilities	32,133	26,045	23,695	17,707	13,596	13,746
Total Current Liabilities	166,931	147,249	132,660	118,261	95,569	88,814
Long-Term Debt	24,000	24,000	-	45	135	225
Long-Term Leases	1,731	340.27	1,043	1,629	106.58	250.75
Pension & Post-Retirement Benefits	-	114.83	1,482	-	-	927.43
Other Long-Term Liabilities	2,113	2,096	2,548	1,988	1,030	1,061
Total Liabilities	194,775	173,800	137,733	121,924	96,841	91,278

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	11,953	11,953	11,953	11,953	11,953	11,953
Additional Paid-In Capital	40,067	40,067	40,067	40,067	40,067	40,067
Retained Earnings	96,691	98,125	98,333	96,033	94,695	94,587
Comprehensive Income & Other	-4,420	-4,408	-4,199	-3,672	-3,012	-907.41
Shareholders' Equity	144,292	145,738	146,154	144,381	143,704	145,701
Total Liabilities & Equity	339,067	319,538	283,887	266,305	240,545	236,979

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	143,029	126,671	91,433	75,936	64,512	56,587
Net Cash (Debt)	-133,078	-118,623	-85,305	-70,589	-57,294	-52,296
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-5569.50	-4961.88	-3567.15	-2952.68	-2439.66	-2190.88
Filing Date Shares Outstanding	23.91	23.91	23.91	23.91	23.91	23.91
Total Common Shares Outstanding	23.91	23.91	23.91	23.91	23.91	23.91
Working Capital	-10,011	11,889	19,281	17,641	20,757	22,352
Book Value Per Share	6035.57	6096.06	6113.48	6039.33	6011.00	6094.52
Tangible Book Value	140,182	141,858	142,146	140,741	140,483	142,346
Tangible Book Value Per Share	5863.68	5933.76	5945.84	5887.05	5876.26	5954.19
Land	32,846	30,146	30,146	28,633	27,569	23,874
Buildings	101,048	92,725	82,779	81,336	79,341	76,851
Machinery	138,991	136,978	125,238	119,358	113,325	111,022
Construction In Progress	33,504	24,850	7,959	1,856	1,444	1,729

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 3, 2026

Data Sources Report a data error